Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Defense
- Agriculture
- Health and Safety
- Air and Climate
- University / Academia / Research
- Manufacturing, Other
- Energy
- Mining
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- Environmental
- Government
- Food and Beverage
- Construction & Construction Materials
Antigen Protein Suppliers Serving Canada
49 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
based inDavis, CALIFORNIA (USA)
Cell Technology was founded in 1998 to provide research solutions for the academic, biotechnology and pharmaceutical industries. Our focus is to develop unique assays that allow researchers to study cellular functions using cell-permeable reagents. ...
based inMunich, GERMANY
ImevaX is a Biotech company based in Munich with a focus on facilitating H. pylori Diagnostics with a novel Rapid Diagnostic ...
(flagellar filament capping protein or flagellar hook-associated protein) is an essential element in the assembly of H. pylori´s flagella. It is an efficient, highly sensitive and specific marker, present in all H. pylori strains worldwide. ...
based inSomerset, NEW JERSEY (USA)
Even the most sophisticated, cutting-edge medical diagnostics aren’t of value unless we can get them to those who need them most. At Access Bio, we believe every life is precious, and every human on earth deserves the opportunity to live a healthy ...
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Triple-negative breast cancer (TNBC) is a highly proliferative, rapidly growing, and aggressive form of cancer. TNBC can be further categorized into three types: Type 1 (also known as the “cold” type) is characterized by a tumor with low ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major ...
based inTrezzano Sul Naviglio (MI), ITALY
Richen Europe S.r.l. is a Pharmaceutical Company founded in 2014 as a subsidiary of the RICHEN MEDICAL SCIENCE GROUP and reference for the European market. We manufacture our own Medical Diagnostic and Medical Instruments focused on Gastroenterology ...
The rapid antigen test has become the most used tool – both publicly and privately – to quickly find out if you have come into contact with the Sars-CoV-2 virus, thus allowing better tracking of infections. ...
based inGosselies, BELGIUM
SYnAbs was founded in 2015 as a Belgian spin-off of the Catholic University of Louvain (UCL), based on the work of Prof. Hervé Bazin, the inventor of the world's first rat myeloma cell line. SYnAbs' vision is to fill the gap on the marketplace for ...
based inWest Vancouver, BRITISH COLUMBIA (CANADA)
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. ...
The mechanism of action of Bria-IMT™/Bria-OTS™ is currently under investigation. We believe that Bria-IMT™/Bria-OTS™, activates the patient’s immune system to recognize tumor cells and destroy them. We hypothesize that ...
based inShirley, NEW YORK (USA)
CD BioSciences is a leading customer-focused biotechnology company founded in New York. Virus-like particles (VLPs) constructed on plant-based platforms can be produced on a large scale as plants can be grown cheaply and efficiently without the need ...
As is a leading global custom service provider, CD BioSciences dedicated to delivering highly customized and integrated solutions with the best quality to advance our customers' projects. CD BioSciences has a sophisticated VLPlantTM platform and ...
based inTaipei City, TAIWAN
Instant NanoBiosensors (INB) is an innovative life sciences company that has developed next generation, ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Our platform , Light ...
INB-D200 and INB-D800 are light-sensing Biomarker Analyzer based on our unique & patented FOPPR™ Technology (Fiber Optic Particle Plasmon Resonance), which takes advantage of multiple total internal reflections in an optical fiber coated ...
based inUppsala, SWEDEN
Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane ...
Abera’s proprietary vaccine delivery platform – BERA, enables high-level multivalent presentation of recombinant antigens on bacterial Outer Membrane Vesicles (OMVs) for strong stimulation of the immune ...
based inShanghai City, CHINA
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma'; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates ...
These vaccines contain information from messenger RNA, including the “blueprint” or code of a specific virus trait (virus antigen). The information enables the body to produce this antigen on its own: ...
based inHercules, CALIFORNIA (USA)
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products ...
Mouse anti Hepatitis B Core Antigen antibody, clone H3A4 (4H5) specifically recognizes Hepatitis B virus core antigen (HBcAg), the highly immunogenic 21kDa replicative form of the Hepatitis B virus (HBV), expressed by infected cells. Antibodies to ...
based inWuhan, CHINA
Wuhan Healthcare Biotechnology Co., Ltd. (Healthcare) is specialized in the production of high quality in vitro diagnostic reagents and instrumentation products that empower clinicians to treat patients faster than before and intended for hospitals, ...
For qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or fingerstick whole blood, venous whole blood specimens from patients suspected of COVID-19 ...
based inNanjing, CHINA
Founded in 2002, Jiji Biotech Co., Ltd.is a medical and health industry chain that integrates independent research and development, large-scale production and professional marketing. It has many subsidiaries and offices at home and abroad. the ...
Test Item: SARS-CoV-2 Antigen. Sample Type: Human nasal swab. Test Time: 15 min. Methodology: Immunofluorescence ...
based inRedwood City, CALIFORNIA (USA)
Meissa Vaccines was founded with a mission to protect people everywhere from deadly respiratory viruses and a commitment to develop innovative technologies capable of delivering effective vaccines at a global scale. Meissa is developing live ...
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and ...
based inWijchen, NETHERLANDS
Future Diagnostics is the obvious choice for in vitro diagnostic (IVD) assay development – for start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market. With 20+ years of expert experience and 150 IVD ...
Besides our services for the development of complete IVD immunoassays, we also offer a conjugation service. This service is normally part of an IVD product development but can also be offered as a separate project. ...
based inEspoo, FINLAND
A truly global company with a proudly Finnish background, Medix Biochemica has offices and manufacturing facilities all around the world. Partnering with us means getting access to international, industry-leading expertise, meaning you can get to ...
Recombinant human pepsinogen I ...
based inHamburg, GERMANY
Since 1983, Viramed is one of the leading biotechnology companies for medical laboratory diagnostics. With more than 30 years of experience in the field of infectious and autoimmune serology, Viramed is a successful enterprise, specializing in the ...